We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 41-60 of 5,490 results
  1. GM-CSF disruption in CART cells modulates T cell activation and enhances CART cell anti-tumor activity

    Inhibitory myeloid cells and their cytokines play critical roles in limiting chimeric antigen receptor T (CART) cell therapy by contributing to the...

    Michelle J. Cox, Claudia Manriquez Roman, ... Saad S. Kenderian in Leukemia
    Article 19 April 2022
  2. B cell‐activating factors in autoimmune pulmonary alveolar proteinosis

    Background

    Autoimmune pulmonary alveolar proteinosis (APAP) results from the suppression of granulocyte-macrophage colony-stimulating factor (GM-CSF)...

    Masaki Hirose, Toru Arai, ... Yoshikazu Inoue in Orphanet Journal of Rare Diseases
    Article Open access 02 March 2021
  3. CMAHP promotes metastasis by reducing ubiquitination of Snail and inducing angiogenesis via GM-CSF overexpression in gastric cancer

    Pseudogenes are generally considered “junk” DNA or “genomic fossils” generated during the evolution process that lack biological activity. However,...

    Hsiang-Wei Huang, Ching-Ying Chen, ... Kwang-Huei Lin in Oncogene
    Article 29 October 2021
  4. Infants with Down syndrome and congenital heart disease have altered peri-operative immune responses

    Background

    Infants with Down syndrome (DS) have an altered immune response. We aimed to characterise the inflammatory response in infants with DS and...

    Lyudmyla Zakharchenko, Afif EL-Khuffash, ... Eleanor J. Molloy in Pediatric Research
    Article Open access 29 March 2022
  5. IL-2/GM-CSF enhances CXCR3 expression in CAR-T cells via the PI3K/AKT and ERK1/2 pathways

    Objective

    To investigate the effects of cytokines IL-2 and GM-CSF on CXCR3 expression and chemotaxis of CAR-T cells.

    Background

    High lymphocyte...

    Liwei Liu, Yan Cheng, ... Bo Liu in Journal of Cancer Research and Clinical Oncology
    Article 06 December 2022
  6. Mesenchymal-epithelial Transition Factor Regulates Monocyte Function during Mycobacterial Infection via Indoleamine 2,3-dioxygenase

    Objective

    Mycobacterium tuberculosis ( Mtb ), the causative agent of tuberculosis (TB), causes an estimated 1.6 million human deaths annually, but the...

    Bing-fen Yang, Fei Zhai, ... **ao-xing Cheng in Current Medical Science
    Article 02 March 2022
  7. Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets

    The immune response holds a pivotal role in cardiovascular disease development. As multifunctional cells of the innate immune system, macrophages...

    Runkai Chen, Hongrui Zhang, ... Canzhao Liu in Signal Transduction and Targeted Therapy
    Article Open access 31 May 2024
  8. Potential involvement of IL-32 in cell-to-cell communication between macrophages and hepatoblastoma

    Purpose

    This study investigated the expression of interleukin 32 (IL-32) in hepatoblastoma, the most common primary pediatric liver tumor, and its...

    Ahmad Adawy, Lianbo Li, ... Taizo Hibi in Pediatric Surgery International
    Article 26 September 2023
  9. VISTA drives macrophages towards a pro-tumoral phenotype that promotes cancer cell phagocytosis yet down-regulates T cell responses

    Background

    VISTA is a well-known immune checkpoint in T cell biology, but its role in innate immunity is less established. Here, we investigated the...

    Yusheng Lin, Ghizlane Choukrani, ... Edwin Bremer in Experimental Hematology & Oncology
    Article Open access 29 March 2024
  10. Functional enhancement of mesothelin-targeted TRuC-T cells by a PD1-CD28 chimeric switch receptor

    T cells expressing a mesothelin (MSLN)-specific T cell receptor fusion construct (TRuC ® ), called TC-210, have demonstrated robust antitumor activity...

    Derrick McCarthy, Michael Lofgren, ... Robert Tighe in Cancer Immunology, Immunotherapy
    Article Open access 18 October 2023
  11. A phase I/II study of LY3022855 with BRAF/MEK inhibition in patients with Melanoma

    BRAF/MEK targeted therapies and immune checkpoint inhibition have dramatically improved disease control and survival of patients with advanced...

    Elizabeth I. Buchbinder, Anita Giobbie-Hurder, ... Patrick A. Ott in Investigational New Drugs
    Article 29 May 2023
  12. The Role of Innate Immune Cells in Allergen Immunotherapy

    Purpose of review

    Allergic diseases have become a major health challenge across the world in recent years. Allergen immunotherapy (AIT) is the only...

    ** Liu, Wen**g Li, Rongfei Zhu in Current Treatment Options in Allergy
    Article 30 May 2023
  13. Macrophages in immunoregulation and therapeutics

    Macrophages exist in various tissues, several body cavities, and around mucosal surfaces and are a vital part of the innate immune system for host...

    Shanze Chen, Abdullah F.U.H. Saeed, ... Yanhong Duo in Signal Transduction and Targeted Therapy
    Article Open access 22 May 2023
  14. Innate immune memory in inflammatory arthritis

    The concept of immunological memory was demonstrated in antiquity when protection against re-exposure to pathogens was observed during the plague of...

    Maxime M. Jeljeli, Iannis E. Adamopoulos in Nature Reviews Rheumatology
    Article 06 September 2023
  15. Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives

    Glioblastoma (GBM), the predominant and primary malignant intracranial tumor, poses a formidable challenge due to its immunosuppressive...

    Hao Lin, Chaxian Liu, ... Ying Mao in Journal of Hematology & Oncology
    Article Open access 08 May 2024
  16. Recent Updates in the Immunopathology of Type 3 Immunity-Mediated Enthesitis

    Purpose of Review

    Enthesitis is a cardinal feature of spondyloarthritis (SpA). Despite increasing available treatments, challenges remain in...

    Akihiro Nakamura, Nigil Haroon in Current Rheumatology Reports
    Article 24 April 2021
  17. Myeloid-derived suppressor cells in cancer: therapeutic targets to overcome tumor immune evasion

    Paradoxically, tumor development and progression can be inhibited and promoted by the immune system. After three stages of immune editing, namely,...

    Junli Lu, Yiming Luo, ... Wenjie Huang in Experimental Hematology & Oncology
    Article Open access 12 April 2024
  18. Autotaxin inhibition attenuates the aortic valve calcification by suppressing inflammation-driven fibro-calcific remodeling of valvular interstitial cells

    Background

    Patients with fibro-calcific aortic valve disease (FCAVD) have lipid depositions in their aortic valve that engender a proinflammatory...

    Dohee Yoon, Bongkun Choi, ... Jae-Kwan Song in BMC Medicine
    Article Open access 14 March 2024
  19. Effect of acute inflammatory reaction induced by biopsy on tumor microenvironment

    When it comes to the diagnosis of solid tumors, biopsy is always the gold standard. However, traumatic and inflammatory stimuli are so closely...

    Yuanyuan Chen, Hualian Liu, Yadong Sun in Journal of Cancer Research and Clinical Oncology
    Article Open access 05 April 2024
  20. Divergent clinical outcomes in a phase 2B trial of the TLPLDC vaccine in preventing melanoma recurrence and the impact of dendritic cell collection methodology: a randomized clinical trial

    Background

    A randomized, double-blind, placebo-controlled phase 2b trial of the tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine was...

    Alexandra M. Adams, Elizabeth L. Carpenter, ... George E. Peoples in Cancer Immunology, Immunotherapy
    Article 01 September 2022
Did you find what you were looking for? Share feedback.